We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 3-DIMENSIONAL PHARMACEUTICALS (DDDP) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (139)1/19/2003 12:52:25 PM
From: jayhawk969  Read Replies (1) | Respond to of 146
I owned Sibia at the time of acquisition. I did not participate in DDDP. However I am in LEXG and the $5 January covered calls expired Friday. ( At least I think they did--the stock closed at $5) I am probably in a position of Liquidating the LEXG regardless. I had a nice 4 month return on the calls and it is probably time to exit. Lexg's cash position looks ok until you factor in restricted cash, and the synthetic lease that is impacted by FASB's new ruling dated January 15/03. It is interesting that J&J is also a collaborator with LEXG. As I recall your last thoughts on LEXG were not overly optimistic.